Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Paul Miller to Serve as Special Advisor to the CEO of Advance Nanotech and Non-Executive Chairman of Advance Homeland Security Inc.

Abstract:
Former Pfizer, Inc. (NYSE: PFE) EVP/General Counsel Brings Specialized Skill Set to Parent Company and Subsidiary

Paul Miller to Serve as Special Advisor to the CEO of Advance Nanotech and Non-Executive Chairman of Advance Homeland Security Inc.

NEW YORK, NY | Posted on March 21st, 2007

Advance Nanotech, Inc., (OTC BB:AVNA), the premier provider of financing and support services to drive the commercialization of nanotechnology related products for homeland security and display technologies today announced that Paul S. Miller will serve as Special Advisor to the CEO of Advance Nanotech and non-executive Chairman of the Company's subsidiary, Advance Homeland Security Inc.

Mr. Miller was Executive Vice President and General Counsel for Pfizer, Inc. (NYSE: PFE), and served on the Pfizer Leadership Committee and Senior Management Committee before retiring from the Company in 2001. During his 30-year tenure with Pfizer, he held numerous positions, including Senior Vice President, Vice President and Associate General Counsel. Following his retirement, Mr. Miller served as Special Counsel to Kaye Scholer LLP, a full service international law firm.

"I'm excited to be working with a company involved in the promising area of nanotechnology," stated Mr. Miller. "I look forward to participating in the development of the cutting-edge technologies in Advance Nanotech's impressive portfolio of companies."

"Paul's prodigious experience gained during his tenure with Pfizer, the worlds largest pharmaceutical company, will be of immediate and long-term benefit to Advance Nanotech, in general, and in particular to the potential application of nanotechnology in the healthcare industry," stated Mr. Goncalves.

Mr. Miller is a member of the Board of Overseers of Rutgers University Foundation, a member of the Board of Governors of Tel Aviv University, a member of the Advisory Board of Corinthian Capital, LP; and a member of the Board of Overseers of the Middle Eastern Institute at RAND.

####

About Advance Nanotech, Inc.
Advance Nanotech identifies patented, patent-pending and proprietary technologies at leading universities and funds the additional development of such technologies in exchange for the exclusive rights to commercialize any resulting products. Advance Nanotech has interests in nanotechnologies which are grouped into two operating subsidiaries: Advance Display Technologies plc, which is listed on the PLUS-Quoted market in London (ADTP) and Advance Homeland Security plc.

By partnering with universities and leveraging the infrastructure and multi-disciplinary human resources of our university partners, we reduce our cost base and mitigate risk. After prototypes are proven within the lab and we develop a product roadmap and business plan, we form majority owned subsidiaries around the specific technology. We seek to return value to our shareholders through the sale or licensing of the technology, by securing additional financing for the subsidiary from either the venture capital community or the capital markets, or by successfully executing our business plan and consolidating its income as the majority shareholder. For more information on Advance Nanotech, please visit http://www.advancenanotech.com .

About Advance Homeland Security, Inc.

Advance Homeland Security Inc., a wholly owned subsidiary of Advance Nanotech Inc. provides homeland security solutions across two application areas: CBRNE Detection (Chemical, Biological, Radiation, Nuclear and Explosive), and Wireless Monitoring for cognitive awareness, triage and first response therapy.

This news release contains forward-looking statements within the meaning of the "safe harbour" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our Annual Report on Form 10-K and 10-K/A, recent and forthcoming Quarterly Reports on Form 10-Q and 10-Q/A, recent Current Reports and other SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

For more information, please click here

Contacts:
ROI Group, LLC
Investor Relations:
Robert Giordano, 212-495-0201

or
Public Relations:
Robin Schoen, 917-292-2954

or
Advance Nanotech, Inc.
Tom Black, 212-583-0080

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Announcements

SEFCU, SUNY Poly CNSE Announce Winning Student-Led Teams in the 6th Annual $500,000 New York Business Plan Competition April 25th, 2015

Northwestern scientists develop first liquid nanolaser: Technology could lead to new way of doing 'lab on a chip' medical diagnostics April 25th, 2015

Nanotech-enabled moisturizer speeds healing of diabetic skin wounds: Spherical nucleic acids silence gene that interferes with wound healing April 24th, 2015

Fast and accurate 3-D imaging technique to track optically trapped particles April 24th, 2015

Homeland Security

UCLA nanoscientists are first to model atomic structures of three bacterial nanomachines: Cryo electron microscope enables scientists to explore the frontiers of targeted antibiotics April 21st, 2015

Optics, nanotechnology combined to create low-cost sensor for gases April 3rd, 2015

The Universitat Politècnica de València is coordinating a European project to develop a device for the quick and early diagnosis of cancer March 7th, 2015

Detecting chemical weapons with a color-changing film January 28th, 2015

Appointments/Promotions/New hires/Resignations/Deaths

Dais Analytic Corporation Appoints Eliza Wang to Board of Directors: Company's Newest Director Brings Expertise in Commercial and Legal Matters Both in the United States and China; Joins on the Heels of Successful Business Development Trade Mission to China April 18th, 2015

Nanion Technologies Appoints James Costantin as Director of Customer Relations: Nanion is pleased to announce the appointment of Dr. James Costantin as Director of Customer Relations at Nanion Technologies Inc. March 31st, 2015

Nanofilm Appoints Senior Sales/Marketing Executives: Don Tecco, Director of Optical Sales, North America and Rex Talbott, Business Director Optical Products March 23rd, 2015

KIT Increases Commitment in Asia: DAAD Funds Two New Projects: Strategic Partnerships with Chinese Universities and Communi-cation Technologies Network February 22nd, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project